SAN DIEGO, March 13, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in a top 30 U.S. market newspaper, Voice of San Diego.
A March 12, 2018, article on the Voice of San Diego website entitled “California Cannabis Finds a Market in Mexico” features interviews with both Medical Marijuana, Inc. CEO Dr. Stuart Titus and subsidiary HempMeds® Mexico’s President of Latin America Raul Elizalde. The article outlines how HempMeds® Mexico became the only company from which residents in Mexico can get legal permits to import cannabidiol (CBD) products with a doctor’s prescription.
In the article, Dr. Titus is quoted saying: “Prior to our intervention, [Mexican President Enrique] Peña Nieto was against all cannabis products, but he was open to a debate. Raul [Elizalde] has been able to change the way the president thinks about cannabis.”
“It was my pleasure to be interviewed by this publication and I hope that this helps spread awareness of all the great work our subsidiary HempMeds Mexico is currently doing,” Titus said. “We want to help expand global access to CBD and end the stigma about cannabis through education.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media
>View original article
Author: Jeffrey Stamberger